Abeona Therapeutics
Price & Volume
Stats
See more52W Range | $3.93-$7.54 |
Market Cap | $292.6M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $400,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$29.2M |
Diluted EPS | $1.21 |
News
See moreYahoo Finance • 13 days ago
Netflix Is Casting a Light on a Rare Disease. Pearl Jam’s Frontman Is Raising Cash to Cure It.
Yahoo Finance • 18 days ago
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
Yahoo Finance • 3 months ago
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
About
CEO | Dr. Vishwas Seshadri M.B.A., Ph.D. |
Address | 6555 Carnegie Avenue, Cleveland, OH, United States, 44103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 136 |
